Company: FORA
Filing Date: 2025-04-11
Form Type: 10-K
Source: 0001140361-25-013493
Chunk: 10

Company: Forian Inc.
Filing Date: 2025-04-11
Form: 10-K
Item: Item 9B
Chunk 10
---
 Director Independence

The information required by this item is incorporated by reference to Forian’s Proxy Statement for its 2025 Annual Meeting of Stockholders to be filed with the SEC within 120
        days after the end of the fiscal year ended December 31, 2024.

    Item 14.

                Principal Accountant Fees and Services

The information required by this item is incorporated by reference to Forian’s Proxy Statement for its 2025 Annual Meeting of Stockholders to be filed with the SEC within 120
        days after the end of the fiscal year ended December 31, 2024.

        97

          Table of Contents

Part IV

    Item 15.

                Exhibits and Financial Statement Schedules

    (a)

              The following documents are filed or furnished as part of this Form 10-K:

    1.

              Financial Statements

Reference is made to the Index to Financial Statements under Item 8, Part II hereof.

    2.

              Financial Statement Schedules

The Financial Statement Schedules have been omitted because they are not applicable, not required, or the information is shown in the financial statements or related notes.

    3.

              Exhibits

EXHIBIT INDEX

              Exhibit
              Number

              Description

              2.1

              Agreement and Plan of Merger, dated as of October 16, 2020, by and among Helix Technologies, Inc., Forian Inc., DNA Merger Sub, Inc. and Medical Outcomes Research Analytics, LLC
                (incorporated by reference to Appendix A of the Company’s Form S-4 (Reg. No. 333-250938) filed with the SEC on November 24, 2020, as amended on December 31, 2020, January 19, 2021, February 1, 2021 and February 9, 2021).

              2.2

              Amendment to Agreement and Plan of Merger dated December 30, 2020, by and among Helix Technologies, Inc., Forian Inc., DNA Merger Sub, Inc. and Medical Outcomes Research Analytics, LLC
                (incorporated by reference to Exhibit 2.2 of the Company’s Form S-4 (Reg. No. 333-250938) filed with the SEC on November 24, 2020, as amended on December 31, 2020, January 19, 2021, February 1